These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 18025232

  • 1. A complement C3 inhibitor specifically targeted to sites of complement activation effectively ameliorates collagen-induced arthritis in DBA/1J mice.
    Song H, Qiao F, Atkinson C, Holers VM, Tomlinson S.
    J Immunol; 2007 Dec 01; 179(11):7860-7. PubMed ID: 18025232
    [Abstract] [Full Text] [Related]

  • 2. Mechanisms of effects of complement inhibition in murine collagen-induced arthritis.
    Banda NK, Kraus D, Vondracek A, Huynh LH, Bendele A, Holers VM, Arend WP.
    Arthritis Rheum; 2002 Nov 01; 46(11):3065-75. PubMed ID: 12428251
    [Abstract] [Full Text] [Related]

  • 3. C2 IgM Natural Antibody Enhances Inflammation and Its Use in the Recombinant Single Chain Antibody-Fused Complement Inhibitor C2-Crry to Target Therapeutics to Joints Attenuates Arthritis in Mice.
    Banda NK, Tomlinson S, Scheinman RI, Ho N, Ramirez JR, Mehta G, Wang G, Vu VP, Simberg D, Kulik L, Holers VM.
    Front Immunol; 2020 Nov 01; 11():575154. PubMed ID: 33178202
    [Abstract] [Full Text] [Related]

  • 4. Prevention of collagen-induced arthritis in mice transgenic for the complement inhibitor complement receptor 1-related gene/protein y.
    Banda NK, Kraus DM, Muggli M, Bendele A, Holers VM, Arend WP.
    J Immunol; 2003 Aug 15; 171(4):2109-15. PubMed ID: 12902517
    [Abstract] [Full Text] [Related]

  • 5. Complement receptor CR2/CR1 deficiency protects mice from collagen-induced arthritis and associates with reduced autoantibodies to type II collagen and citrullinated antigens.
    Kuhn KA, Cozine CL, Tomooka B, Robinson WH, Holers VM.
    Mol Immunol; 2008 May 15; 45(10):2808-19. PubMed ID: 18374982
    [Abstract] [Full Text] [Related]

  • 6. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA, Lubberts E, Helsen MM, Saxne T, Coenen-de Roo CJ, Heinegård D, van den Berg WB.
    Arthritis Res; 1999 May 15; 1(1):81-91. PubMed ID: 11056663
    [Abstract] [Full Text] [Related]

  • 7. The human complement receptor type 2 (CR2)/CR1 fusion protein TT32, a novel targeted inhibitor of the classical and alternative pathway C3 convertases, prevents arthritis in active immunization and passive transfer mouse models.
    Fridkis-Hareli M, Storek M, Or E, Altman R, Katti S, Sun F, Peng T, Hunter J, Johnson K, Wang Y, Lundberg AS, Mehta G, Banda NK, Michael Holers V.
    Mol Immunol; 2019 Jan 15; 105():150-164. PubMed ID: 30513451
    [Abstract] [Full Text] [Related]

  • 8. Low-dose targeted complement inhibition protects against renal disease and other manifestations of autoimmune disease in MRL/lpr mice.
    Atkinson C, Qiao F, Song H, Gilkeson GS, Tomlinson S.
    J Immunol; 2008 Jan 15; 180(2):1231-8. PubMed ID: 18178863
    [Abstract] [Full Text] [Related]

  • 9. Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection.
    Atkinson C, Song H, Lu B, Qiao F, Burns TA, Holers VM, Tsokos GC, Tomlinson S.
    J Clin Invest; 2005 Sep 15; 115(9):2444-53. PubMed ID: 16127466
    [Abstract] [Full Text] [Related]

  • 10. Targeted inhibition of the complement alternative pathway with complement receptor 2 and factor H attenuates collagen antibody-induced arthritis in mice.
    Banda NK, Levitt B, Glogowska MJ, Thurman JM, Takahashi K, Stahl GL, Tomlinson S, Arend WP, Holers VM.
    J Immunol; 2009 Nov 01; 183(9):5928-37. PubMed ID: 19828624
    [Abstract] [Full Text] [Related]

  • 11. Blockade of antibody-induced glomerulonephritis with Crry-Ig, a soluble murine complement inhibitor.
    Quigg RJ, Kozono Y, Berthiaume D, Lim A, Salant DJ, Weinfeld A, Griffin P, Kremmer E, Holers VM.
    J Immunol; 1998 May 01; 160(9):4553-60. PubMed ID: 9574562
    [Abstract] [Full Text] [Related]

  • 12. Complement deficiency ameliorates collagen-induced arthritis in mice.
    Hietala MA, Jonsson IM, Tarkowski A, Kleinau S, Pekna M.
    J Immunol; 2002 Jul 01; 169(1):454-9. PubMed ID: 12077276
    [Abstract] [Full Text] [Related]

  • 13. Administration of a soluble recombinant complement C3 inhibitor protects against renal disease in MRL/lpr mice.
    Bao L, Haas M, Kraus DM, Hack BK, Rakstang JK, Holers VM, Quigg RJ.
    J Am Soc Nephrol; 2003 Mar 01; 14(3):670-9. PubMed ID: 12595503
    [Abstract] [Full Text] [Related]

  • 14. Complement Inhibition Alleviates Cholestatic Liver Injury Through Mediating Macrophage Infiltration and Function in Mice.
    Guo Z, Chen J, Zeng Y, Wang Z, Yao M, Tomlinson S, Chen B, Yuan G, He S.
    Front Immunol; 2021 Mar 01; 12():785287. PubMed ID: 35069557
    [Abstract] [Full Text] [Related]

  • 15. Complement plays an important role in spinal cord injury and represents a therapeutic target for improving recovery following trauma.
    Qiao F, Atkinson C, Song H, Pannu R, Singh I, Tomlinson S.
    Am J Pathol; 2006 Sep 01; 169(3):1039-47. PubMed ID: 16936276
    [Abstract] [Full Text] [Related]

  • 16. A new treatment for neurogenic inflammation caused by EV71 with CR2-targeted complement inhibitor.
    Qiu S, Liu N, Jia L, Yang G, Su W, Li J, Song L, Yang C, Wang J, Zhang C, Wang Z, Qiao F, Tomlinson S, Atkinson C, Sun Y, Huang L, Song H, Wang Y, Li Z.
    Virol J; 2012 Nov 23; 9():285. PubMed ID: 23173749
    [Abstract] [Full Text] [Related]

  • 17. Targeted Complement Inhibition Protects Vascularized Composite Allografts From Acute Graft Injury and Prolongs Graft Survival When Combined With Subtherapeutic Cyclosporine A Therapy.
    Zhu P, Bailey SR, Lei B, Paulos CM, Atkinson C, Tomlinson S.
    Transplantation; 2017 Apr 23; 101(4):e75-e85. PubMed ID: 28045880
    [Abstract] [Full Text] [Related]

  • 18. Alternative complement pathway activation is essential for inflammation and joint destruction in the passive transfer model of collagen-induced arthritis.
    Banda NK, Thurman JM, Kraus D, Wood A, Carroll MC, Arend WP, Holers VM.
    J Immunol; 2006 Aug 01; 177(3):1904-12. PubMed ID: 16849503
    [Abstract] [Full Text] [Related]

  • 19. Complement-dependent P-selectin expression and injury following ischemic stroke.
    Atkinson C, Zhu H, Qiao F, Varela JC, Yu J, Song H, Kindy MS, Tomlinson S.
    J Immunol; 2006 Nov 15; 177(10):7266-74. PubMed ID: 17082645
    [Abstract] [Full Text] [Related]

  • 20. Mechanisms of inhibition of collagen-induced arthritis by murine IL-18 binding protein.
    Banda NK, Vondracek A, Kraus D, Dinarello CA, Kim SH, Bendele A, Senaldi G, Arend WP.
    J Immunol; 2003 Feb 15; 170(4):2100-5. PubMed ID: 12574381
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.